Publication dates

Chemotherapy Industry, July 2014 Market Reports from Top Publishers

You might be interested in: flow cytometry, hematology, cancer, more »


 
1-10 of 84 reports for Chemotherapy

InvivoGen Therapeutics - Product Pipeline Review - 2014

InvivoGen Therapeutics - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

... Pei-dna 12product description 12mechanism of action 12r&d progress 12plasmid gene therapy for chemotherapy-induced thrombocytopenia 14product description 14 ...

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Pipeline projects- coverage of the chemotherapy induced neutropenia pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline ...

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • June 2014
  • by Infiniti Research Limited

... Analysis07. Rate of incidence and prevalence08. Market segmentation by type of therapy08.1.1 chemotherapy08.1.2 Targeted therapy09. Pipeline portfolio10. Geographical ...

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2014

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Therapeutic landscape of chemotherapy induced nausea and vomiting- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

MidCentral District Health Board SWOT Analysis, Strategy, Revenues and Profits

MidCentral District Health Board SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... To coast, cardiology, cardiology unit, cervical screening, chemotherapy, and child and youth health services. Mdhb also offers child health, children's ward, dannevirke health service, dental health ...

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Patient population suffering from xerostomia and radiation dermatitis. These products provide relief to cancer patients undergoing radiation therapy or chemotherapy and patients suffering from sjogren ...

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Therapeutic landscape of chemotherapy induced peripheral neuropathy- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

... Diagnosis 112.6 Prognosis and disease staging 122.6.1 Classification 132.7 Treatment options 142.7.1 Surgery and radiation therapy 142.7.2 chemotherapy 142.7.3 Hormonal therapies 15 ...

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

... The current standard of care, comprising resection surgery, radiation therapy and chemotherapy with merck's temodar (temozolomide), has a maximum overall survival (os) of 15 months and almost inevitable tumor ...

 Chemotherapy Induced Nausea and Vomiting- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Chemotherapy Induced Nausea and Vomiting- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... Key discontinued marketed products. - Global sales figure from 2011-2015.Reasons to buy - evaluate the marketing status and exclusivity details of chemotherapy induced nausea ...

About 3 200 reports for Chemotherapy

Download Unlimited Documents from Trusted Public Sources

The future of the Chemotherapy Industry in China

  • Hepatic Histopathology and Postoperative Outcome after Preoperat...
  • January 2012
    7 pages
  • Chemotherapy  

  • China  

View report >

Canada - Country Risk

September 2012

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.